BioLineRx Stock Forecast - Simple Exponential Smoothing
| BLRX Stock | USD 3.10 0.14 4.73% |
The Simple Exponential Smoothing forecasted value of BioLineRx on the next trading day is expected to be 3.05 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.86. BioLineRx Stock Forecast is based on your current time horizon.
At this time the rsi of BioLineRx's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using BioLineRx hype-based prediction, you can estimate the value of BioLineRx from the perspective of BioLineRx response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of BioLineRx on the next trading day is expected to be 3.05 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.86. BioLineRx after-hype prediction price | USD 3.1 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BioLineRx | Build AI portfolio with BioLineRx Stock |
BioLineRx Additional Predictive Modules
Most predictive techniques to examine BioLineRx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BioLineRx using various technical indicators. When you analyze BioLineRx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
BioLineRx Simple Exponential Smoothing Price Forecast For the 24th of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of BioLineRx on the next trading day is expected to be 3.05 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.86.Please note that although there have been many attempts to predict BioLineRx Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that BioLineRx's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
BioLineRx Stock Forecast Pattern
| Backtest BioLineRx | BioLineRx Price Prediction | Buy or Sell Advice |
BioLineRx Forecasted Value
In the context of forecasting BioLineRx's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. BioLineRx's downside and upside margins for the forecasting period are 0.03 and 6.25, respectively. We have considered BioLineRx's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of BioLineRx stock data series using in forecasting. Note that when a statistical model is used to represent BioLineRx stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.6768 |
| Bias | Arithmetic mean of the errors | 0.0167 |
| MAD | Mean absolute deviation | 0.081 |
| MAPE | Mean absolute percentage error | 0.0252 |
| SAE | Sum of the absolute errors | 4.8612 |
Predictive Modules for BioLineRx
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioLineRx. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.BioLineRx After-Hype Price Prediction Density Analysis
As far as predicting the price of BioLineRx at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in BioLineRx or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of BioLineRx, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
BioLineRx Estimiated After-Hype Price Volatility
In the context of predicting BioLineRx's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on BioLineRx's historical news coverage. BioLineRx's after-hype downside and upside margins for the prediction period are 0.16 and 6.30, respectively. We have considered BioLineRx's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
BioLineRx is risky at this time. Analysis and calculation of next after-hype price of BioLineRx is based on 3 months time horizon.
BioLineRx Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as BioLineRx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BioLineRx backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with BioLineRx, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.27 | 3.20 | 0.00 | 0.01 | 0 Events / Month | 1 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.10 | 3.10 | 0.00 |
|
BioLineRx Hype Timeline
BioLineRx is currently traded for 3.10. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. BioLineRx is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at -0.27%. %. The volatility of related hype on BioLineRx is about 7441.86%, with the expected price after the next announcement by competition of 3.09. The company has price-to-book (P/B) ratio of 0.63. Some equities with similar Price to Book (P/B) outperform the market in the long run. BioLineRx has Price/Earnings To Growth (PEG) ratio of 0.2. The entity recorded a loss per share of 6.0. The firm last dividend was issued on the 15th of July 2019. BioLineRx had 1:40 split on the 30th of January 2025. Given the investment horizon of 90 days the next projected press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of BioLineRx to cross-verify your projections.BioLineRx Related Hype Analysis
Having access to credible news sources related to BioLineRx's direct competition is more important than ever and may enhance your ability to predict BioLineRx's future price movements. Getting to know how BioLineRx's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how BioLineRx may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| THAR | Tharimmune | 0.00 | 0 per month | 5.13 | 0 | 8.88 | (9.23) | 35.56 | |
| GOVX | GeoVax Labs | 0.00 | 0 per month | 0.00 | (0.27) | 9.38 | (13.70) | 42.89 | |
| ADAP | Adaptimmune Therapeutics Plc | 0.00 | 0 per month | 0.00 | (0.86) | 1.86 | (12.20) | 14.05 | |
| APLM | Apollomics Class A | 0.00 | 0 per month | 9.38 | (0.0009) | 17.08 | (14.50) | 44.38 | |
| ANL | Adlai Nortye Ltd | (0.20) | 9 per month | 5.69 | 0.12 | 10.27 | (11.76) | 42.22 | |
| ADTX | Aditxt Inc | (0.23) | 5 per month | 0.00 | (0.24) | 22.54 | (27.59) | 63.67 | |
| MBRX | Moleculin Biotech | 0.00 | 0 per month | 0.00 | (0.20) | 9.37 | (11.73) | 41.63 | |
| AIMD | Ainos Inc | 0.00 | 0 per month | 0.00 | (0.19) | 6.71 | (9.79) | 28.00 | |
| ICU | SeaStar Medical Holding | 0.00 | 0 per month | 0.00 | (0.16) | 9.58 | (9.88) | 34.66 | |
| LNAI | Lunai Bioworks | 0.00 | 0 per month | 5.92 | 0 | 12.62 | (8.82) | 55.92 |
Other Forecasting Options for BioLineRx
For every potential investor in BioLineRx, whether a beginner or expert, BioLineRx's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BioLineRx Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BioLineRx. Basic forecasting techniques help filter out the noise by identifying BioLineRx's price trends.BioLineRx Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioLineRx stock to make a market-neutral strategy. Peer analysis of BioLineRx could also be used in its relative valuation, which is a method of valuing BioLineRx by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
BioLineRx Market Strength Events
Market strength indicators help investors to evaluate how BioLineRx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioLineRx shares will generate the highest return on investment. By undertsting and applying BioLineRx stock market strength indicators, traders can identify BioLineRx entry and exit signals to maximize returns.
| Accumulation Distribution | 2100.03 | |||
| Daily Balance Of Power | 0.875 | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 3.02 | |||
| Day Typical Price | 3.05 | |||
| Price Action Indicator | 0.15 | |||
| Period Momentum Indicator | 0.14 |
BioLineRx Risk Indicators
The analysis of BioLineRx's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BioLineRx's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biolinerx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.59 | |||
| Standard Deviation | 3.2 | |||
| Variance | 10.24 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for BioLineRx
The number of cover stories for BioLineRx depends on current market conditions and BioLineRx's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BioLineRx is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BioLineRx's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
BioLineRx Short Properties
BioLineRx's future price predictability will typically decrease when BioLineRx's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of BioLineRx often depends not only on the future outlook of the potential BioLineRx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioLineRx's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 79.9 M | |
| Cash And Short Term Investments | 19.6 M |
Additional Tools for BioLineRx Stock Analysis
When running BioLineRx's price analysis, check to measure BioLineRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLineRx is operating at the current time. Most of BioLineRx's value examination focuses on studying past and present price action to predict the probability of BioLineRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLineRx's price. Additionally, you may evaluate how the addition of BioLineRx to your portfolios can decrease your overall portfolio volatility.